scholarly article | Q13442814 |
P50 | author | Ditte C. Andersen | Q42830801 |
Pia Jeppesen | Q46159805 | ||
Jakob Lerche Hansen | Q54992089 | ||
Anne Yael Nossent | Q55098202 | ||
P2093 | author name string | Steen Gammeltoft | |
Mikael Schneider | |||
Tilde Eskildsen | |||
Gitte Lund Christensen | |||
Søren Paludan Sheikh | |||
Hasse Brønnum Jensen | |||
P2860 | cites work | Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. | Q43922018 |
Arrestins block G protein-coupled receptor-mediated apoptosis | Q44820320 | ||
Murine "cardiospheres" are not a source of stem cells with cardiomyogenic potential. | Q45139526 | ||
Identification of functional angiotensin II receptors on rat cardiac fibroblasts | Q46184530 | ||
Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells | Q46662936 | ||
The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts | Q53021334 | ||
Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes | Q53558215 | ||
Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. | Q54792697 | ||
Guide to Receptors and Channels (GRAC), 4th Edition | Q56639335 | ||
AT1 receptor Gαq protein-independent signalling transcriptionally activates only a few genes directly, but robustly potentiates gene regulation from the β2-adrenergic receptor | Q63208651 | ||
Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes | Q71601468 | ||
Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy | Q71620642 | ||
Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice | Q73030690 | ||
Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts | Q73661346 | ||
Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors | Q73841698 | ||
Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition | Q74662431 | ||
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis | Q24337549 | ||
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis | Q24537628 | ||
MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis | Q24634064 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy | Q28281648 | ||
Effect of cysteamine on redox-sensitive thiol-containing proteins in the duodenal mucosa | Q28569428 | ||
{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation | Q28577649 | ||
An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo | Q28578913 | ||
Control of stress-dependent cardiac growth and gene expression by a microRNA | Q28587851 | ||
MicroRNA-133 controls cardiac hypertrophy | Q29616572 | ||
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data | Q29616810 | ||
Gene regulatory networks in the evolution and development of the heart | Q29619086 | ||
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure | Q29619548 | ||
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists | Q34122067 | ||
Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor | Q34548751 | ||
Microtranscriptome regulation by gonadotropin-releasing hormone | Q34974789 | ||
Cell-cell contact globally activates microRNA biogenesis. | Q34975000 | ||
Regulatory circuit of human microRNA biogenesis | Q35753722 | ||
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system | Q36548154 | ||
Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor | Q37432858 | ||
Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks | Q37448085 | ||
Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription | Q38296408 | ||
Beta-arrestin-mediated signaling regulates protein synthesis. | Q39782848 | ||
Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cells | Q39856113 | ||
Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation. | Q39863122 | ||
A novel Galphaq/11-selective inhibitor | Q40520558 | ||
Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state | Q42482690 | ||
Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response | Q42789926 | ||
MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes. | Q42827656 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 394-404 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes | |
P478 | volume | 164 |
Q44307084 | Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts |
Q37007126 | Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans |
Q46949305 | Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts |
Q90171814 | Angiotensin-(1-9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway |
Q88956304 | Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis |
Q35251097 | Cardiac Insulin Resistance and MicroRNA Modulators |
Q35558398 | Heterotrimeric G protein-mediated signaling and its non-canonical regulation in the heart |
Q90478773 | Interactions Among Non-Coding RNAs in Diabetic Nephropathy |
Q33112080 | Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells. |
Q87448990 | MicroRNA as a novel component of the tissue renin angiotensin system |
Q37419073 | MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway. |
Q38133419 | MicroRNAs: potential regulators of renal development genes that contribute to CAKUT. |
Q44145967 | Pharmacogenomics of antihypertensive drug response: new evidence of miRNA controlling blood pressure |
Q38190443 | Regulatory RNAs and paracrine networks in the heart. |
Q38833827 | Regulatory mechanisms in arterial hypertension: role of microRNA in pathophysiology and therapy |
Q39006068 | Role of MicroRNA in Endothelial Dysfunction and Hypertension |
Q64924544 | Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension. |
Q35625794 | Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling |
Q92337905 | Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR-1-dependent pathway |
Q64254485 | Tetrahydroxy stilbene glucoside alleviates palmitic acid-induced inflammation and apoptosis in cardiomyocytes by regulating miR-129-3p/Smad3 signaling |
Q35178127 | The ACE2/Apelin Signaling, MicroRNAs, and Hypertension |
Q51024991 | The association of circulating miR-30a, miR-29 and miR-133 with white-coat hypertension |
Q35786347 | The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury |
Q45097264 | The microRNA-132/212 family fine-tunes multiple targets in Angiotensin II signalling in cardiac fibroblasts |
Q37204328 | miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy |